Cargando…
Monoclonal Antibodies Addressed to Factors of Signalization in Keloid Scars: Opportunities and Areas of Action
The advance of technology has made possible the use of new techniques within medicine for the treatment of diseases; monoclonal antibodies are a clear example of this. Keloid scars are one of the most difficult pathologies to treat due to the high percentage of recidivism, formed by the growth of a...
Autores principales: | Moreno Pizarro, Erick, Morales Valencia, Eduardo, Pérez Cuéllar, Arturo, Acuña Pinzon, Camilo, Serrano Padilla, Aarón Emanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389189/ https://www.ncbi.nlm.nih.gov/pubmed/32742861 http://dx.doi.org/10.7759/cureus.8894 |
Ejemplares similares
-
Combined Surgical Approach to Intracranial and Extracranial Hemangiopericytoma: Case Report and Literature Review
por: Morales Valencia, Eduardo, et al.
Publicado: (2020) -
Reconstructed human keloid models show heterogeneity within keloid scars
por: Limandjaja, Grace C., et al.
Publicado: (2018) -
The Use of Chemotherapeutics for the Treatment of Keloid Scars
por: Jones, Christopher David, et al.
Publicado: (2015) -
The Roles of Inflammation in Keloid and Hypertrophic Scars
por: Wang, Zheng-Cai, et al.
Publicado: (2020) -
Pruritus in Keloid Scars: Mechanisms and Treatments
por: HAWASH, Ahmed A., et al.
Publicado: (2021)